TLSI Latest News, Press Relases and Analysis

All

Press Releases

a day ago - By: Zacks Investment Research - Mentions: ICUI

ICU Medical (ICUI) Surpasses Q3 Earnings and Revenue Estimates

2 days ago - By: Zacks Investment Research - Mentions: BTMD

biote Corp. (BTMD) Tops Q3 Earnings and Revenue Estimates

9 days ago - By: TriSalus Life Sciences

TriSalus Life Sciences to Host Third Quarter 2025 Financial Results Conference Call

2 months ago - By: TriSalus Life Sciences

TriSalus Life Sciences to Participate in Upcoming September Investor Conferences

8 months ago - By: Benzinga

Examining the Future: TriSalus Life Sciences's Earnings Outlook

3 months ago - By: Zacks Investment Research - Mentions: MDT

TriSalus Life Sciences, Inc. (TLSI) Reports Q2 Loss, Tops Revenue Estimates

3 months ago - By: TriSalus Life Sciences

TriSalus Life Sciences Reports Second Quarter 2025 Results and Reiterates 2025 Guidance

3 months ago - By: Zacks Investment Research - Mentions: MYO

Myomo, Inc. (MYO) Reports Q2 Loss, Tops Revenue Estimates

3 months ago - By: TriSalus Life Sciences

TriSalus Life Sciences Announces Publication of Safety and Efficacy Results for a Novel Pressure-Enabled Thyroid Embolization Technique

3 months ago - By: Benzinga - Mentions: BKV IMCC VALN PRTS ...

Earnings Scheduled For August 12, 2025

3 months ago - By: Zacks Investment Research - Mentions: ZBH

Zimmer Biomet (ZBH) Beats Q2 Earnings and Revenue Estimates

3 months ago - By: TriSalus Life Sciences

TriSalus Life Sciences to Participate in the Canaccord Genuity 45th Annual Growth Conference

3 months ago - By: TriSalus Life Sciences

TriSalus Life Sciences to Host Second Quarter 2025 Financial Results Conference Call

4 months ago - By: TriSalus Life Sciences

TriSalus Life Sciences Announces Expiration and Results of Exchange Offer and Consent Solicitation Relating to Series A Convertible Preferred Stock

5 months ago - By: TriSalus Life Sciences

TriSalus Life Sciences Announces Commencement of Exchange Offer and Consent Solicitation Relating to Series A Convertible Preferred Stock to Streamline Capital Structure

5 months ago - By: TriSalus Life Sciences

TriSalus Life Sciences Announces the Launch of the TriNav FLX Infusion System

5 months ago - By: TriSalus Life Sciences

TriSalus Life Sciences Announces Chief Financial Officer Transition With Appointment of David B. Patience

6 months ago - By: Zacks Investment Research - Mentions: CGC

TriSalus Life Sciences, Inc. (TLSI) Reports Q1 Loss, Lags Revenue Estimates

6 months ago - By: TriSalus Life Sciences

TriSalus Life Sciences Reports First Quarter 2025 Results and Provides Updated 2025 Guidance

6 months ago - By: Zacks Investment Research - Mentions: OGI

OrganiGram (OGI) Reports Q2 Loss, Beats Revenue Estimates (Revised)

6 months ago - By: TriSalus Life Sciences

TriSalus Life Sciences to Host First Quarter 2025 Financial Results Conference Call

6 months ago - By: Zacks Investment Research - Mentions: OGI

OrganiGram (OGI) Reports Q2 Loss, Misses Revenue Estimates

6 months ago - By: Zacks Investment Research

TerrAscend Corp. (TSNDF) Reports Q1 Loss, Lags Revenue Estimates

6 months ago - By: TriSalus Life Sciences

TriSalus Life Sciences Announces $22.0 Million Private Placement Preliminary Q1 2025 Unaudited Financial Results

8 months ago - By: Stocktwits - Mentions: DWX IMFL

TriSalus Life Sciences’ Q4 Loss Exceeds Projections, Revenue Tops Estimates – Retail Stays Pessimistic

8 months ago - By: Zacks Investment Research - Mentions: ABT

TriSalus Life Sciences, Inc. (TLSI) Reports Q4 Loss, Tops Revenue Estimates

8 months ago - By: TriSalus Life Sciences

TriSalus Life Sciences Reports Q4 and Full Year 2024 Financial Results and Provides Business Update

8 months ago - By: TriSalus Life Sciences

TriSalus Life Sciences Announces New CMS HCPCS Code for TriNav® Infusion System Mapping

8 months ago - By: TriSalus Life Sciences

TriSalus Life Sciences® Announces That Its Researchers Received Two JVIR Top Paper Awards for the Publication of “Intra-arterial Pressure-Enabled Drug Delivery™ Significantly Increases Penetration of Glass Microspheres in a Porcine Liver Tumor Model”

9 months ago - By: TriSalus Life Sciences

TriSalus Life Sciences Announces Key Appointments to Board of Directors

9 months ago - By: TriSalus Life Sciences

TRISALUS LIFE SCIENCES INC (TLSI) Stock News

TLSI Latest News, Press Relases and Analysis

ICU Medical (ICUI) Surpasses Q3 Earnings and Revenue Estimates

biote Corp. (BTMD) Tops Q3 Earnings and Revenue Estimates

TriSalus Life Sciences to Host Third Quarter 2025 Financial Results Conference Call

TriSalus Life Sciences to Participate in Upcoming September Investor Conferences

Examining the Future: TriSalus Life Sciences's Earnings Outlook

TriSalus Life Sciences, Inc. (TLSI) Reports Q2 Loss, Tops Revenue Estimates

TriSalus Life Sciences Reports Second Quarter 2025 Results and Reiterates 2025 Guidance

Myomo, Inc. (MYO) Reports Q2 Loss, Tops Revenue Estimates

TriSalus Life Sciences Announces Publication of Safety and Efficacy Results for a Novel Pressure-Enabled Thyroid Embolization Technique

Earnings Scheduled For August 12, 2025

Zimmer Biomet (ZBH) Beats Q2 Earnings and Revenue Estimates

TriSalus Life Sciences to Participate in the Canaccord Genuity 45th Annual Growth Conference

TriSalus Life Sciences to Host Second Quarter 2025 Financial Results Conference Call

TriSalus Life Sciences Announces Expiration and Results of Exchange Offer and Consent Solicitation Relating to Series A Convertible Preferred Stock

TriSalus Life Sciences Announces Commencement of Exchange Offer and Consent Solicitation Relating to Series A Convertible Preferred Stock to Streamline Capital Structure

TriSalus Life Sciences Announces the Launch of the TriNav FLX Infusion System

TriSalus Life Sciences Announces Chief Financial Officer Transition With Appointment of David B. Patience

TriSalus Life Sciences, Inc. (TLSI) Reports Q1 Loss, Lags Revenue Estimates

TriSalus Life Sciences Reports First Quarter 2025 Results and Provides Updated 2025 Guidance

OrganiGram (OGI) Reports Q2 Loss, Beats Revenue Estimates (Revised)

TriSalus Life Sciences to Host First Quarter 2025 Financial Results Conference Call

OrganiGram (OGI) Reports Q2 Loss, Misses Revenue Estimates

TerrAscend Corp. (TSNDF) Reports Q1 Loss, Lags Revenue Estimates

TriSalus Life Sciences Announces $22.0 Million Private Placement Preliminary Q1 2025 Unaudited Financial Results

TriSalus Life Sciences’ Q4 Loss Exceeds Projections, Revenue Tops Estimates – Retail Stays Pessimistic

TriSalus Life Sciences, Inc. (TLSI) Reports Q4 Loss, Tops Revenue Estimates

TriSalus Life Sciences Reports Q4 and Full Year 2024 Financial Results and Provides Business Update

TriSalus Life Sciences Announces New CMS HCPCS Code for TriNav® Infusion System Mapping

TriSalus Life Sciences® Announces That Its Researchers Received Two JVIR Top Paper Awards for the Publication of “Intra-arterial Pressure-Enabled Drug Delivery™ Significantly Increases Penetration of Glass Microspheres in a Porcine Liver Tumor Model”

TriSalus Life Sciences Announces Key Appointments to Board of Directors

TriSalus Life Sciences Announces Drawdown of $10 Million Tranche Under Credit Agreement with OrbiMed